$157 Million is the total value of HighVista Strategies LLC's 86 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -22,434 | -100.0% | -0.12% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -20,659 | -100.0% | -0.15% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -58,965 | -100.0% | -0.33% | – |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -65,068 | -100.0% | -0.38% | – | |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -50,942 | -100.0% | -0.38% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -18,796 | -100.0% | -0.43% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -40,612 | -100.0% | -0.46% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -89,220 | -100.0% | -0.60% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -46,264 | -100.0% | -0.65% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -38,347 | -100.0% | -0.67% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -54,012 | -100.0% | -0.69% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -39,777 | -100.0% | -0.73% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -56,901 | -100.0% | -0.78% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -29,753 | -100.0% | -0.78% | – |
| Exit | AADI BIOSCIENCE INC | $0 | – | -40,549 | -100.0% | -0.78% | – | |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -13,843 | -100.0% | -1.18% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -89,963 | -100.0% | -1.27% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -21,433 | -100.0% | -1.59% | – |
| CONE | Exit | CYRUSONE INC | $0 | – | -38,700 | -100.0% | -2.76% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -64,841 | -100.0% | -2.86% | – |
| INFO | Exit | IHS MARKIT LTD | $0 | – | -32,743 | -100.0% | -3.46% | – |
| XLNX | Exit | XILINX INC | $0 | – | -24,173 | -100.0% | -4.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.